Todd Alfred Carter
Chief Scientific Officer · Voyager Therapeutics, Inc.
- 2026
- Feb 26, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd Alfred Carter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alfred Sandrock - $184K in VYGR purchases and sales in the last 12 months
- Robin Swartz - $55K in VYGR purchases and sales in the last 12 months
- Nathan D. Jorgensen - $18K in VYGR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Todd Alfred Carter?
Todd Alfred Carter is a corporate insider, tracked as Chief Scientific Officer of Voyager Therapeutics, Inc. (VYGR). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Todd Alfred Carter last file a Form 4?
The most recent primary Form 4 on record is dated 26 February 2026, one of 4 filings going back to 2026.
Has Todd Alfred Carter been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($41K) across all tracked filings.
